On Tuesday, Merck ( MRK -1.56%) wasn't one of the better-performing pharmaceutical stocks. In contrast to certain peers, the company's share price declined following the release of second-quarter ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

Novo Nordisk A/S stock dips after 2025 guidance cut. However, click for why NVO's strong GLP-1 prospects, growing pipeline, ...

The stock now trades at one of its lowest price-to-earnings ratios in years. The Danish pharmaceutical giant announced it was ...

Consumers are already stretched thin, so rate cuts may not significantly boost spending or spark runaway inflation as many fear. Click for more on U.S. Economy.

Novo Nordisk stock took a big hit early Tuesday after the Danish weight-loss drugmaker unexpectedly cut its full-year guidance for the U.S.It also announced a new CEO, appointing an insider to lead ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.

A formal trade agreement between the US and EU introduces a 15% tariff on most EU exports, including pharmaceuticals, ...

Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...

Health plans should directly contract with drug manufacturers to provide medications at transparent and affordable prices, ...

Shares in Danish drugmaker Novo Nordisk were down nearly 20% in pre-market trading Tuesday morning after the company cuts its sales and profit estimates.

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...